PMID- 24732868 OWN - NLM STAT- MEDLINE DCOM- 20140805 LR - 20220318 IS - 1572-0241 (Electronic) IS - 0002-9270 (Print) IS - 0002-9270 (Linking) VI - 109 IP - 6 DP - 2014 Jun TI - Acid-based parameters on pH-impedance testing predict symptom improvement with medical management better than impedance parameters. PG - 836-44 LID - 10.1038/ajg.2014.63 [doi] AB - OBJECTIVES: pH-impedance testing detects reflux events irrespective of pH, but its value in predicting treatment outcome is unclear. We prospectively evaluated subjects treated medically after pH-impedance testing to determine predictors of symptom improvement. METHODS: Subjects referred for pH-impedance testing completed questionnaires in which dominant symptoms and global symptom severity (GSS) were recorded. Acid-reflux parameters (acid-exposure time, AET; symptom association by Ghillebert probability estimate, GPE; symptom index, SI) and impedance reflux parameters (reflux-exposure time, RET; number of reflux events; GPE and SI with impedance data) were extracted. Symptoms and GSS were prospectively reevaluated after medical therapy. Univariate and multivariate analyses determined predictors of GSS improvement following medical management. RESULTS: Over 5 years, 128 subjects (mean 53.3+/-1.3 years, 66.4% female; typical symptoms 57.0%, 53.9% tested on therapy) underwent pH-impedance testing and subsequent medical therapy for reflux symptoms, and completed required questionnaires. On follow-up 3.35+/-0.14 years later, mean GSS declined by 45.0%, with 42.2% patients reporting >/=50% GSS improvement. On univariate analysis, total AET, AET>/=4.0%, and GPE for all reflux events predicted both linear and >/=50% GSS improvement, but RET and number of reflux events did not. On multivariate analysis, controlling for testing on or off therapy, only AET (P=0.003) and GPE for all reflux events (P=0.029) predicted GSS improvement. CONCLUSIONS: Acid-based reflux parameters offer greater value over impedance-based nonacid-reflux parameters in predicting symptomatic responses to proton pump inhibitor (PPI) therapy. Our findings support conducting pH-impedance studies off PPI therapy to maximize clinical utility in predicting outcome. FAU - Patel, Amit AU - Patel A AD - Division of Gastroenterology, Washington University School of Medicine, Saint Louis, Missouri, USA. FAU - Sayuk, Gregory S AU - Sayuk GS AD - Division of Gastroenterology, Washington University School of Medicine, Saint Louis, Missouri, USA. FAU - Gyawali, C Prakash AU - Gyawali CP AD - Division of Gastroenterology, Washington University School of Medicine, Saint Louis, Missouri, USA. LA - eng GR - T32 DK007130/DK/NIDDK NIH HHS/United States GR - 5P30 DK 052574-14-AP/DK/NIDDK NIH HHS/United States GR - R21 DK084413/DK/NIDDK NIH HHS/United States GR - K23DK84413-4 -GSS/DK/NIDDK NIH HHS/United States GR - P30 DK052574/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20140415 PL - United States TA - Am J Gastroenterol JT - The American journal of gastroenterology JID - 0421030 SB - IM MH - Adult MH - Aged MH - *Electric Impedance MH - Esophageal pH Monitoring MH - Esophagus/*physiopathology MH - Female MH - Gastroesophageal Reflux/*diagnosis/physiopathology MH - Humans MH - Hydrogen-Ion Concentration MH - Male MH - Middle Aged MH - Prospective Studies MH - Surveys and Questionnaires MH - Treatment Outcome PMC - PMC4104528 MID - NIHMS598843 COIS- CONFLICT OF INTEREST Potential competing interests: None. EDAT- 2014/04/16 06:00 MHDA- 2014/08/06 06:00 PMCR- 2015/06/01 CRDT- 2014/04/16 06:00 PHST- 2013/09/30 00:00 [received] PHST- 2014/02/11 00:00 [accepted] PHST- 2014/04/16 06:00 [entrez] PHST- 2014/04/16 06:00 [pubmed] PHST- 2014/08/06 06:00 [medline] PHST- 2015/06/01 00:00 [pmc-release] AID - ajg201463 [pii] AID - 10.1038/ajg.2014.63 [doi] PST - ppublish SO - Am J Gastroenterol. 2014 Jun;109(6):836-44. doi: 10.1038/ajg.2014.63. Epub 2014 Apr 15.